NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
11/17/2025
Back to search
Official data from USPTO
PARTNERSHIP FOR ACCELERATING CANCER THERAPIES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PARTNERSHIP FOR ACCELERATING CANCER THERAPIES
ST13
US500000087979166Class
35, 36
Filing
87979166
Registration
5658275
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
11/18/2025
Trademark type
Word
Nice classes
35, 36
Filing date
08/31/2017
Registration date
01/15/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/17/2025
Last transaction
11/18/2025
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
10/12/2017
First use in commerce
10/12/2017
Drawing code
4
Owner type
99
Owner location
Bethesda, MD
Examiner
MARTINS, ODETTE
Current location
Historical data usage
Holders and representatives
Holders
U.S. Department of Health and Human Services
Representatives
Angela Y. Dai HHS OFFICE OF THE GENERAL COUNSEL
Technical classification
Nice Classes
Class 35Class 36
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business management and business development servicesmanagement of research grantsbusiness program managementpromoting collaboration within the scientificresearchacademicprovider communities to achieve advances in the field of human health; Promotion of biomedical research programs of others
Class 36
Providing grants and financial support to researcherscompanieshealth care providers for biomedical research
Publications
History of USPTO decisions and trademark events.
39 publications found
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
11/17/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/17/2025
ES8R
TEAS SECTION 8 RECEIVED
07/15/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/15/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/04/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/04/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
01/04/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/04/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/04/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/04/2021
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
01/15/2019
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/11/2018
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
12/04/2018
DPCC
DIVISIONAL PROCESSING COMPLETE
11/26/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/21/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/13/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/13/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/09/2018
DRRR
DIVISIONAL REQUEST RECEIVED
11/08/2018
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
11/08/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/15/2018
GNRT
NON-FINAL ACTION E-MAILED
05/15/2018
CNRT
NON-FINAL ACTION WRITTEN
05/15/2018
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
04/24/2018
IUAA
USE AMENDMENT ACCEPTED
04/22/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/17/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/17/2018
ALIE
ASSIGNED TO LIE
04/16/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/04/2018
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
04/04/2018
IUAF
USE AMENDMENT FILED
04/04/2018
EAAU
TEAS AMENDMENT OF USE RECEIVED
04/03/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/10/2017
GNRT
NON-FINAL ACTION E-MAILED
10/10/2017
CNRT
NON-FINAL ACTION WRITTEN
10/10/2017
DOCK
ASSIGNED TO EXAMINER
09/28/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/08/2017
NWAP
NEW APPLICATION ENTERED
09/04/2017
Continuous trademark protection
Get notified about every new filing that threatens PARTNERSHIP FOR ACCELERATING CANCER THERAPIES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.